Randomized controlled trials in PD

Nephrology Dialysis Transplantation

Volumn 22, Issue 10, 2007, Pages 2746-2748

  Blake, Peter G ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Automated peritoneal dialysis; Peritoneal dialysis; Peritoneal dialysis solutions; Randomized controlled trials

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GENTAMICIN; ICODEXTRIN; PSEUDOMONIC ACID;

CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HUMAN; KIDNEY FUNCTION; MORTALITY; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; QUALITY OF LIFE; SHORT SURVEY; ULTRAFILTRATION;

DIALYSIS SOLUTIONS; HUMANS; NEPHROLOGY; PERITONEAL DIALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 36048954507     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm173     Document Type: Short Survey

References (29)

1. Rabindranath K, Adams K, Ali T, Daly C, Vale L, Macleod A. Automated vs continuous ambulatory peritoneal dialysis: A systematic review of randomized controlled trials. Nephrol Dial Trans 2007; 22: 2991-2998
2. Perez RA, Blake PG, Jindal KA, Badovinac K, Trpeski L, Fenton SS. Changes in peritoneal dialysis practices in Canada 1996-1999. Perit Dial Int 2003; 23: 53-57
3. Blake P, Burkart JM, Churchill DN et al. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16: 448-456
4. de Fijter CW, Oe LP, Nauta JJ et al. Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 1994; 120: 264-271
5. Rodriguez-Carmona A, Perez-Fontan MP. Sodium removal in patients undergoing CAPD and automated peritoneal dialysis. Perit Dial Int 2002; 22: 705-713
6. Ortega O, Gallar P, Carreno A et al. Peritoneal sodium removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control. Am J Nephrol 2001; 21: 189-193
7. Paniagua R, Amato D, Vonesh E et al. Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. Am Soc Nephrol 2002; 13: 1307-1320
8. Maiorca R, Cantaluppi A, Cancarini GC et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983; 2: 642-644
9. Canadian CAPD Clinical Trials Group.Peritonitis in continuous ambulatory peritoneal dialysis: a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 1989; 9: 159-163
10. Kiernan L, Kliger A, Gorban-Brennan N et al. Comparison of CAPD related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 1995; 5: 1835-1838
11. Mupirocin Study Group.Nasal mupirocin prevents Staphylococcus aureus exit site infection during peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2403-2408
12. Singh AK, Szczech L, Tang KL et al. CHOIR Investigators. Correction of anemia with epoetin alpha in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
13. Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on CAPD. Kidney Int 2001; 59: 1128-1133
14. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized controlled study. An Intern Med 2003; 139: 105-112
15. Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis 2004; 43: 1056-1064
16. Lo WK, Ho YW, Li CS et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 2003; 64: 649-656
17. Monteon F, Corra-Rotter R, Paniagua R et al. Prevention of peritonitis with disconnect systems in CAPD. The Mexican Nephrology Collaborative Study Group. Kidney Int 1998; 54: 2123-2128
18. Bernardini J, Bender F, Florio T et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16: 539-545
19. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperisosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994; 46: 496-503
20. Davies SJ, Woodrow G, Donovan K et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-2344
21. Konings CJ, Kooman JP, Schonck M et al. Effect of icodextrin on volume status, blood pressure and echographic parameters: a randomized study. Kidney Int 2003; 63: 1556-1563
22. Li FK, Chan LY, Woo JC et al. A 3-year prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis 2003; 42: 173-183
23. Williams JD, Topley N, Craig KJ et al. The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004; 66: 408-418
24. Szeto CC, Chow KM, Lam CW et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products - 1-year randomized control trial. Nephrol Dial Transplant 2007; 22: 552-559
25. Fusshoeller A, Plail M, Grabensee B, Plum J. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant 2004; 19: 2101-2106
26. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol. 2003; 14: 2119-2126
27. Fouque D, Peng SC, Shamir E, Kopple JD. Recombinant human insulin-like growth factor-I induces an anabolic response in malnurished CAPD patients. Kidney Int 2000; 57: 646-654
28. Leung CB, Szeto CC, Chow KM et al. Cefazolin plus ceftazidime versus imip[enem/cliastatin monotherapoy for treatment of peritonitis. Perit Dial Int 2004; 24: 440-446
29. Johnson DW, Wong J, Wiggins KJ et al. A randomized controlled trial of coiled versus straight swan-necked Tenckhoff catheters in peritoneal dialysis patients. Am J Kidney Dis 2006; 48: 812-821